000 01296 a2200349 4500
005 20250514010610.0
264 0 _c20011004
008 200110s 0 0 eng d
022 _a0090-3493
024 7 _a10.1097/00003246-200109000-00027
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSchellinger, P D
245 0 0 _aThrombolytic therapy for ischemic stroke--a review. Part I--Intravenous thrombolysis.
_h[electronic resource]
260 _bCritical care medicine
_cSep 2001
300 _a1812-8 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aFibrinolytic Agents
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aInjections, Intravenous
650 0 4 _aRandomized Controlled Trials as Topic
650 0 4 _aStreptokinase
_xadministration & dosage
650 0 4 _aStroke
_xdrug therapy
650 0 4 _aTissue Plasminogen Activator
_xadministration & dosage
650 0 4 _aUrokinase-Type Plasminogen Activator
_xadministration & dosage
700 1 _aFiebach, J B
700 1 _aMohr, A
700 1 _aRingleb, P A
700 1 _aJansen, O
700 1 _aHacke, W
773 0 _tCritical care medicine
_gvol. 29
_gno. 9
_gp. 1812-8
856 4 0 _uhttps://doi.org/10.1097/00003246-200109000-00027
_zAvailable from publisher's website
999 _c11469690
_d11469690